Experimental models of breast cancer confirm a role for RHAMM in promoting functions associated with breast tumor initiation and metastasis [13–15] predicting that targeting this protein may improve clinical management of breast cancer metastases. This evidence concerns the gene HMMR and breast carcinoma.